Protect Yourself: The Importance of Papillomavirus Vaccination

On World Papillomavirus Day, March 4th, French President Emmanuel Macron announced a “generalised” vaccination campaign against the Human Papillomavirus (H.P.V.) in schools.” Papillomavirus infections are prevalent and usually harmless, but in some cases, they can lead to the development of pre-cancerous lesions. In fact, these infections are responsible for approximately 6,000 reported cases of cancer in both women and men. The World Health Organization (W.H.O.) has stated that screening and vaccination efforts could lead to the elimination of H.P.V. infections. However, despite the ten-year strategy to combat cancer, from 2021 to 2030, aiming for an 80% coverage rate within seven years, the current vaccination rates in France are concerning, with only 37% of girls and 9% of boys receiving the vaccine. Children between the ages of 11 and 14 are advised to have the immunization, which can be given as a catch-up shot til the age of 19. Men who engage in sexual activity with other men can receive the H.P.V. vaccine until they are 26 years old.

A two-year study of the vaccine, conducted in the French Grand Est region, had positive findings among fifth-grade pupils, with vaccination rates rising from 9% to 27% in the first year and 14% to 31% in the second. Vaccination campaigns to eliminate cervical cancer within 15 years are being conducted in schools in Australia, where the prevalence of H.P.V. infection has decreased from 22.7% in 2005–2007 to 1.5% in 2015 among women aged 18–24. President Macron emphasized the significance of the vaccine in preventing a wide range of cancers during his announcement. The French campaign will begin with fifth graders in the upcoming academic year.

Common sexually transmitted diseases like H.P.V. can result in significant health issues like throat, cervical, and anal cancer. Given that there are over 14 million new cases of H.P.V. each year, early intervention is critical in preventing the spread of the virus. The H.P.V. vaccine is advised for all boys and girls from 11 years old, though in some cases, it is distributed from 9 years old. Depending on the recipient’s age, the vaccination is administered over two or three injections six months apart.

Despite the HPV vaccine being readily available, several people remain unvaccinated. People may choose not to receive the vaccine for various reasons, such as uncertainty about its efficacy and safety, lack of access to healthcare, and inaccurate information regarding H.P.V. Public health officials and medical professionals are attempting to raise knowledge about the value of the vaccination and trying to make it more widely available to communities lacking access to standard medical care.

Safe sex habits are essential in preventing the spread of H.P.V. This entails using condoms during sexual activity, restricting the number of partners, and undergoing routine cervical cancer screenings. Pre-cancerous cells can be found early, when they are most curable, through regular screenings. The prevention of H.P.V. also depends on educating young people about the risks involved and the methods to protect themselves such as vaccinations, practicing safe sex behaviours, and undergoing routine cervical cancer screenings. A comprehensive strategy encompassing these various steps can help stop the spread of H.P.V and lower the incidence of H.P.V.-related cancer cases.